A groundbreaking new publication entitled, Targeting Signaling Cascades by Bioactive Phytocompounds in Osteosarcoma: A Novel Therapeutic Approach, has been published in the esteemed journal Pharmacology and Therapeutics (Impact Factor: 12.5) by Elsevier.
This article represents an impressive achievement, not only for cancer research, but also for the College of Osteopathic Medicine at LECOM. The first seven coauthors of this publication are current LECOM students or recent graduates, showcasing the dedication and cutting-edge contributions of LECOM scholars to the medical community.
Osteosarcoma, an aggressive and often devastating primary malignant bone tumor, presents a significant challenge for clinicians and researchers. While traditional treatments like chemotherapy, surgery, and radiation remain the standard, these therapies can be associated with harsh side effects and limited effectiveness. To address this problem, innovative research into alternative therapeutic strategies, including the use of bioactive phytochemicals, has gained increasing attention.
In this publication, LECOM scholars have taken a major step forward by conducting a thorough, systematic review of the current evidence on the potential of bioactive phytochemicals in preventing and treating osteosarcoma. These natural compounds, derived from plants, have shown great promise in influencing key molecular and cellular processes that drive the growth and spread of cancer cells.
What makes this review exceptional is its depth and breadth. The LECOM team conducted a comprehensive examination of various classes of phytochemicals, such as flavonoids, alkaloids, terpenoids, and polyphenols, and studied their effects upon osteosarcoma in preclinical models. Beyond simply reviewing existing data, the authors carefully explored the molecular and cellular targets of these bioactive compounds, including their role in critical pathways like apoptosis, cell cycle regulation, and angiogenesis. These insights could provide the key to overcoming the challenges associated with traditional therapies, offering new avenues for more effective and less toxic treatment options for osteosarcoma patients.
The team’s meticulous work provides an expansive, systematic review that could serve as a foundation for future research on the role of bioactive phytochemicals in cancer therapy, especially in the context of osteosarcoma. This study represents a forward-thinking approach to medicine, offering potential for translating laboratory findings into real-world therapeutic strategies.
As part of a curriculum that emphasizes clinical education and research, LECOM ensures that its students are equipped to tackle complex healthcare challenges from multiple angles. This publication is a prime example of the way in which LECOM is nurturing the next generation of osteopathic physicians and researchers who are making lasting contributions to advancing medical science and improving patient care.
Access the Full Article:
For those interested in delving into the details of this groundbreaking research, the article can be accessed through the following links:
Journal Website – Targeting Signaling Cascades by Bioactive Phytochemicals in Osteosarcoma: A Novel Therapeutic Approach:
https://www.sciencedirect.com/science/article/abs/pii/S0163725826000410?via%3Dihub)
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41791679/)